Inventurus Knowledge Solutions Limited's Nomination and Remuneration Committee has approved the grant of 12,700 employee stock options to eligible employees under the IKS ESOP Plan on April 28, 2026. Each option is convertible into one fully paid-up equity share with a face value of Re. 1. The options are being granted at an exercise price of Rs. 1,505.20 per option, which is not less than the closing price on BSE Limited on April 27, 2026. The scheme is compliant with SEBI (SBEB) Regulations, 2021.

Inventurus Knowledge Solutions Grants 12,700 Employee Stock Options Under ESOP Plan 2022

Inventurus Knowledge Solutions Limited's Nomination and Remuneration Committee has approved the grant of 12,700 employee stock options to eligible employees under the IKS ESOP Plan on April 28, 2026. The approval was granted pursuant to the provisions of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.

Key Details of ESOP Grant

The employee stock options are being granted under the company's ESOP Plan 2022, which is administered through a trust. Each option granted is convertible into one fully paid-up equity share with a face value of Re. 1. The options are being granted at an exercise price of Rs. 1,505.20 per option, which is not less than the market price—the closing price on BSE Limited on April 27, 2026, being the trading day immediately preceding the date of the committee's approval.

ESOP Scheme Parameters

Particulars Details Options Granted 12,700 employee stock options Face Value Re. 1 per equity share Exercise Price Rs. 1,505.20 per option SEBI (SBEB) Regulations, 2021 Compliant Yes Total Shares Covered 12,700 equity shares

Vesting and Exercise Terms

The stock options granted shall be capable of being exercised anytime during the entire period of continuous active employment from the date of vesting of the respective options. The scheme provides for the manner in which stock options would be dealt with in case of death, permanent incapacity, resignation, termination, retirement, and other scenarios. In case of corporate actions such as rights issue, bonus issue, split or consolidation of equity shares, merger, amalgamation, or sale of division, requisite adjustments shall be appropriately made in accordance with the IKS ESOP Plan.

The equity shares allotted pursuant to the exercise of the stock options would not be subject to lock-in. The disclosure has been made to BSE Limited and National Stock Exchange of India Limited under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Inventurus Knowledge Solutions has announced that its U.S. subsidiary IKS Health has entered into a definitive agreement to acquire TruBridge Inc., a prominent provider of healthcare technology solutions for rural and community hospitals. The strategic acquisition, valued at $26.25 per share in cash, represents a significant expansion into the rural healthcare market.

Strategic Acquisition Details

The transaction has been approved by the Boards of Directors of both companies and is expected to close during the third calendar quarter of 2026, subject to customary closing conditions including shareholder approvals and Hart-Scott-Rodino notification requirements. TruBridge's largest shareholders, representing approximately 27% of outstanding shares, have entered into voting agreements supporting the transaction.

Transaction Parameter: Details Acquisition Price: $26.25 per share in cash Expected Closing: Q3 2026 Shareholder Support: 27% of outstanding shares committed Financing: Term loan underwritten by Citibank, JPMorgan, Deutsche Bank

Conference Call Announcement

Following the acquisition announcement, Inventurus Knowledge Solutions has scheduled a conference call with investors and analysts under Regulation 30 of SEBI Listing Regulations. The company has provided the conference call details at short notice given the significance of the TruBridge acquisition announcement.

Conference Call Details: Information Date: Friday, April 24, 2026 Time: 08:30 AM IST Universal Access: +91 22 6280 1144 / +91 22 7115 8045 International Access: USA: 18667462133, UK: 08081011573

Market Expansion and Integration Strategy

The acquisition combines TruBridge's Electronic Health Record platform with IKS Health's AI-powered Care Enablement Platform to create an integrated healthcare operating system. Post-closing, the combined entity will serve more than 2,000 healthcare organizations and over 150,000 clinicians with AI-driven and human-led solutions.

Combined Entity Metrics: Scale Healthcare Organizations: 2,000+ Clinicians Served: 150,000+ Market Opportunity: $575M+ whitespace in existing client base Rural Hospital Coverage: 25-30% of all rural hospitals

Technology and Financial Synergies

The transaction leverages TruBridge's specialized technologies including TruCode medical encoder with 95% coding accuracy and Viewgol analytics platform. The company has previously outlined targeting ₹3,000 crore in EBITDA for the combined entity by FY30, with synergy realization expected over a 3-year timeframe.

Technology Asset: Key Features TruCode Encoder: 6M+ built-in rules, 95% accuracy Viewgol Platform: Predictive analytics, real-time dashboards EHR Solutions: Specialized for rural and community hospitals Combined EBITDA Target: ₹3,000 crore by FY30

Leadership and Market Focus

Sachin K. Gupta, Founder and Global CEO of IKS Health, emphasized the acquisition's role in extending proven clinician-first experience to the rural and community hospital market. Chris Fowler, President and CEO of TruBridge, highlighted the shared passion for improving provider experiences and financial results in rural healthcare settings.

The acquisition addresses the challenge that nearly one in five Americans face in accessing care, with TruBridge's deep expertise in supporting rural and community hospitals through revenue cycle management and EHR solutions. The combined platform will incorporate broader clinical and financial data to become increasingly intelligent and efficient through agentic artificial intelligence with human-in-the-loop expertise.

Post-closing, TruBridge will be delisted from NASDAQ and become a wholly-owned subsidiary, while Inventurus Knowledge Solutions shares will continue trading on the National Stock Exchange of India. The transaction represents IKS Health's commitment to building a comprehensive care ecosystem for all types of healthcare organizations.

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.

As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.